CYP2C19-rs4986893 confers risk to major depressive disorder and bipolar disorder in the Han Chinese population whereas ABCB1-rs1045642 acts as a protective factor

[1]  M. Schwandt,et al.  Leptin Gene and Leptin Receptor Gene Polymorphisms in Alcohol Use Disorder: Findings Related to Psychopathology , 2021, Frontiers in Psychiatry.

[2]  Aiste Lengvenyte,et al.  CYP2C19 polymorphisms are associated with severity of depression at initial evaluation and after the treatment independently of the prescribed medications: 4 weeks prospective study , 2021, Psychiatric genetics.

[3]  C. Ferrario,et al.  Insulin Bidirectionally Alters NAc Glutamatergic Transmission: Interactions between Insulin Receptor Activation, Endogenous Opioids, and Glutamate Release , 2021, The Journal of Neuroscience.

[4]  A. Serretti,et al.  How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach , 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[5]  N. Bokhan,et al.  NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder , 2020, Frontiers in Genetics.

[6]  M. Bellgrove,et al.  Impact of CYP2C19 genotype-predicted enzyme activity on hippocampal volume, anxiety, and depression , 2020, Psychiatry Research.

[7]  L. Pozzo-Miller,et al.  Dysfunction of the corticostriatal pathway in autism spectrum disorders , 2019, Journal of neuroscience research.

[8]  H. Schiöth,et al.  Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI , 2019, Translational Psychiatry.

[9]  A. Wingo,et al.  Association of HLA locus alleles with posttraumatic stress disorder , 2019, Brain, Behavior, and Immunity.

[10]  David A. Lewis,et al.  Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder , 2019, Translational Psychiatry.

[11]  E. Pothos,et al.  Impact of Brain Insulin Signaling on Dopamine Function, Food Intake, Reward, and Emotional Behavior , 2019, Current Nutrition Reports.

[12]  David L. Bennett,et al.  The Role of Voltage-Gated Sodium Channels in Pain Signaling. , 2019, Physiological reviews.

[13]  R. Alarcón,et al.  Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications , 2019, Front. Pharmacol..

[14]  Qian Zhou,et al.  LRP6 Knockdown Ameliorates Insulin Resistance via Modulation of Autophagy by Regulating GSK3β Signaling in Human LO2 Hepatocytes , 2019, Front. Endocrinol..

[15]  Steven P. Miller,et al.  Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18 months , 2019, EBioMedicine.

[16]  Chen Zhang,et al.  Replicated associations of FADS1, MAD1L1, and a rare variant at 10q26.13 with bipolar disorder in Chinese population , 2018, Translational Psychiatry.

[17]  K. Lesch,et al.  Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment , 2018, CNS neuroscience & therapeutics.

[18]  G. He,et al.  Association study between ABCB1, ABCB6 and ABCG1 polymorphisms and major depressive disorder in the Chinese Han population , 2018, Psychiatry Research.

[19]  Shao-Wu Ou,et al.  Distribution and function of voltage-gated sodium channels in the nervous system , 2017, Channels.

[20]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[21]  D. Zarcone,et al.  Shared mechanisms of epilepsy, migraine and affective disorders , 2017, Neurological Sciences.

[22]  B. Baune,et al.  Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment , 2017, Molecular Psychiatry.

[23]  L. Bierut,et al.  Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression , 2017, Molecular Psychiatry.

[24]  Hui Li,et al.  Correlations of PTEN genetic polymorphisms with the risk of depression and depressive symptoms in a Chinese population. , 2016, Gene.

[25]  O. Andreassen,et al.  The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample , 2016, BMC Psychiatry.

[26]  M. Talarowska,et al.  The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report , 2015, International journal of medical sciences.

[27]  Jiawei Shen,et al.  The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population. , 2015, Journal of affective disorders.

[28]  Yan Yu,et al.  Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population , 2015, Neuropsychiatric disease and treatment.

[29]  C. Uluoğlu,et al.  ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population , 2014, Pharmacological reports : PR.

[30]  K. Goto,et al.  Implication of P-Glycoprotein in Formation of Depression-Prone Personality: Association Study between the C3435T MDR1 Gene Polymorphism and Interpersonal Sensitivity , 2014, Neuropsychobiology.

[31]  A. Cruz,et al.  Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals. , 2014, Genetic testing and molecular biomarkers.

[32]  D. Kupfer,et al.  Bipolar disorder diagnosis: challenges and future directions , 2013, The Lancet.

[33]  M. Ota,et al.  Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population. , 2012, Journal of psychiatric research.

[34]  I. Lee,et al.  The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder , 2010, Pharmacogenetics and genomics.

[35]  J. Rubenstein,et al.  Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer , 2009, Molecular Psychiatry.

[36]  A. Windemuth,et al.  Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital. , 2008, Personalized medicine.

[37]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[38]  A. Llerena,et al.  Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5‐HTTLPR‐S) and the CYP2C9*3 allele , 2007, Fundamental & clinical pharmacology.

[39]  T. Asada,et al.  MDR1 gene polymorphism in Japanese patients with schizophrenia and mood disorders including depression. , 2006, Biological & pharmaceutical bulletin.

[40]  T. Saleh,et al.  Role of Polymorphic Human Cytochrome P450 Enzymes in Estrone Oxidation , 2006, Cancer Epidemiology Biomarkers & Prevention.

[41]  H. Ujike,et al.  The GABA type A receptor α5 subunit gene is associated with bipolar I disorder , 2005, Neuroscience Letters.

[42]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[43]  M. Uhr,et al.  Penetration of Endogenous Steroid Hormones Corticosterone, Cortisol, Aldosterone and Progesterone into the Brain is Enhanced in Mice Deficient for Both mdr1a and mdr1b P‐Glycoproteins , 2002, Journal of neuroendocrinology.

[44]  Y. Terzi,et al.  No Interaction Between Childhood Maltreatment and Serotonin Transporter Gene in Recurrent Major Depressive Disorder: A Clinical Sample. , 2019, Noro psikiyatri arsivi.

[45]  Y. Fang,et al.  Advance in Diagnosis of Depressive Disorder. , 2019, Advances in experimental medicine and biology.

[46]  U. Dannlowski,et al.  Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment , 2017, Molecular Psychiatry.

[47]  H. Ujike,et al.  The GABA type A receptor alpha5 subunit gene is associated with bipolar I disorder. , 2005, Neuroscience letters.

[48]  R. Berecz,et al.  CYP2C9 gene and susceptibility to major depressive disorder , 2003, The Pharmacogenomics Journal.